TY  - GEN
AU  - Lashinger,Laura M
AU  - Zhu,Keyi
AU  - Williams,Simon A
AU  - Shrader,Marissa
AU  - Dinney,Colin P N
AU  - McConkey,David J
TI  - Bortezomib abolishes tumor necrosis factor-related apoptosis-inducing ligand resistance via a p21-dependent mechanism in human bladder and prostate cancer cells
SN  - 0008-5472
PY  - 2005///0728
KW  - Apoptosis
KW  - drug effects
KW  - Apoptosis Regulatory Proteins
KW  - Boronic Acids
KW  - pharmacology
KW  - Bortezomib
KW  - Caspase 3
KW  - Caspase 8
KW  - Caspases
KW  - metabolism
KW  - Cell Cycle Proteins
KW  - Cell Line, Tumor
KW  - Cyclin-Dependent Kinase Inhibitor p21
KW  - Drug Resistance, Neoplasm
KW  - Drug Synergism
KW  - Enzyme Activation
KW  - Humans
KW  - Male
KW  - Membrane Glycoproteins
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Pyrazines
KW  - TNF-Related Apoptosis-Inducing Ligand
KW  - Tumor Necrosis Factor-alpha
KW  - Urinary Bladder Neoplasms
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S
UR  - https://doi.org/10.1158/0008-5472.CAN-04-3701
ER  -